114 related articles for article (PubMed ID: 11607014)
1. Huntington's disease. Exploiting expression.
Bates GP
Nature; 2001 Oct; 413(6857):691, 693-4. PubMed ID: 11607014
[No Abstract] [Full Text] [Related]
2. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
Steffan JS; Bodai L; Pallos J; Poelman M; McCampbell A; Apostol BL; Kazantsev A; Schmidt E; Zhu YZ; Greenwald M; Kurokawa R; Housman DE; Jackson GR; Marsh JL; Thompson LM
Nature; 2001 Oct; 413(6857):739-43. PubMed ID: 11607033
[TBL] [Abstract][Full Text] [Related]
3. Polyglutamine disease: acetyltransferases awry.
Hughes RE
Curr Biol; 2002 Feb; 12(4):R141-3. PubMed ID: 11864588
[TBL] [Abstract][Full Text] [Related]
4. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
Bates EA; Victor M; Jones AK; Shi Y; Hart AC
J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
[TBL] [Abstract][Full Text] [Related]
5. PGC-1alpha, a new therapeutic target in Huntington's disease?
McGill JK; Beal MF
Cell; 2006 Nov; 127(3):465-8. PubMed ID: 17081970
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death).
Sadri-Vakili G; Cha JH
Curr Alzheimer Res; 2006 Sep; 3(4):403-8. PubMed ID: 17017871
[TBL] [Abstract][Full Text] [Related]
7. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
Li SH; Li XJ
Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
[TBL] [Abstract][Full Text] [Related]
8. Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.
Cong SY; Pepers BA; Evert BO; Rubinsztein DC; Roos RA; van Ommen GJ; Dorsman JC
Mol Cell Neurosci; 2005 Sep; 30(1):12-23. PubMed ID: 15994095
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics of Huntington's Disease.
Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M
Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552
[TBL] [Abstract][Full Text] [Related]
10. Huntington's disease: genetics lends a hand.
Palfi S; Jarraya B
Nature; 2008 Jun; 453(7197):863-4. PubMed ID: 18488017
[No Abstract] [Full Text] [Related]
11. Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis.
Glajch KE; Sadri-Vakili G
J Huntingtons Dis; 2015; 4(1):1-15. PubMed ID: 25813218
[TBL] [Abstract][Full Text] [Related]
12. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.
Jiang H; Poirier MA; Liang Y; Pei Z; Weiskittel CE; Smith WW; DeFranco DB; Ross CA
Neurobiol Dis; 2006 Sep; 23(3):543-51. PubMed ID: 16766198
[TBL] [Abstract][Full Text] [Related]
13. Blocking the association of HDAC4 with MAP1S accelerates autophagy clearance of mutant Huntingtin.
Yue F; Li W; Zou J; Chen Q; Xu G; Huang H; Xu Z; Zhang S; Gallinari P; Wang F; McKeehan WL; Liu L
Aging (Albany NY); 2015 Oct; 7(10):839-53. PubMed ID: 26540094
[TBL] [Abstract][Full Text] [Related]
14. Inconsistencies in histone acetylation patterns among different HD model systems and HD post-mortem brains.
Narayan P; Reid S; Scotter EL; McGregor AL; Mehrabi NF; Singh-Bains MK; Glass M; Faull RLM; Snell RG; Dragunow M
Neurobiol Dis; 2020 Dec; 146():105092. PubMed ID: 32979507
[TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration. A glutamine-rich trail leads to transcription factors.
Freiman RN; Tjian R
Science; 2002 Jun; 296(5576):2149-50. PubMed ID: 12077389
[No Abstract] [Full Text] [Related]
16. Epigenetic modifications as novel therapeutic targets for Huntington's disease.
Wang F; Fischhaber PL; Guo C; Tang TS
Epigenomics; 2014 Jun; 6(3):287-97. PubMed ID: 25111483
[TBL] [Abstract][Full Text] [Related]
17. Biomedicine. Huntingtin--profit and loss.
Trottier Y; Mandel JL
Science; 2001 Jul; 293(5529):445-6. PubMed ID: 11463904
[No Abstract] [Full Text] [Related]
18. Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation.
Igarashi S; Morita H; Bennett KM; Tanaka Y; Engelender S; Peters MF; Cooper JK; Wood JD; Sawa A; Ross CA
Neuroreport; 2003 Mar; 14(4):565-8. PubMed ID: 12657886
[TBL] [Abstract][Full Text] [Related]
19. An intriguing new lead on Huntington's disease.
Barinaga M
Science; 1996 Mar; 271(5253):1233-4. PubMed ID: 8638101
[No Abstract] [Full Text] [Related]
20. Clinical Genetics, II. Huntington's disease: from the gene to pathophysiology.
DiFiglia M
Am J Psychiatry; 1997 Aug; 154(8):1046. PubMed ID: 9247386
[No Abstract] [Full Text] [Related]
[Next] [New Search]
